CD8A and lung carcinoma: In addition, we demonstrated that CD8+ T cells in a patient with lung cancer exhibited lower expression of cytotoxic marker PRF1 and activation marker CD69 in co-cultured with A549 for 24 h compared to a healthy volunteer (Fig. 5D).